Corvus Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Corvus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $768K, a 43% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.58M, a 11.6% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.15M, a 20.2% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.69M, a 36.4% decline from 2021.
  • Corvus Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.23M, a 26.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.15M -$545K -20.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $2.69M -$1.54M -36.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $4.23M -$1.52M -26.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-19
2020 $5.75M -$1.6M -21.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 $7.35M +$213K +2.99% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $7.14M +$906K +14.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 $6.23M +$2.4M +62.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 $3.83M +$3.4M +794% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $428K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.